RESEARCH

Pharmaceutical Economics, Big Data Analysis & Policy Lab

Articles

Cost‑Efectiveness and Value of Information of Cabozantinib Treatment for Patients with Advanced Renal Cell Carcinoma After Failure of Prior Therapy in South Korea
Author
Kim S, Han S, Kim H, Suh HS.
Journal
Applied Health Economics and Health Policy
Volume(Issue)
19(4)
Page
545-555
Publication Date
2021.07.

PMID: 33651367

DOI: 10.1007/s40258-021-00640-w